Science & Research
Oragenics Receives Australian Approval for Phase II Concussion Trial
Biotechnology company Oragenics has secured regulatory approval to launch a Phase II clinical trial for ONP-002, a novel intranasal therapy targeting mild traumatic brain injury. The trial represents a potential advancement in treating concussions with a non-invasive approach.
CNS Pharmaceuticals Secures Orphan Drug Designation for Brain Cancer Treatment
CNS Pharmaceuticals has transferred Orphan Drug Designation for TPI 287, a promising microtubule-stabilizing drug targeting brain cancer and neurological conditions. The designation could provide significant market advantages and potential treatment options for patients with challenging neurological disorders.
SeaStar Medical Advances Kidney Injury Treatment with Innovative Pediatric Therapy
SeaStar Medical's QUELIMMUNE therapy offers promising treatment for pediatric acute kidney injury, with FDA approval and early hospital adoption signaling potential breakthrough in a critical healthcare challenge.
Second Medical Opinions Do Not Delay Critical Breast Cancer Treatment
A new study reveals that seeking a second medical opinion after a breast cancer diagnosis does not significantly postpone treatment initiation, potentially providing patients with greater confidence in their treatment strategy without compromising timely care.
Oragenics to Discuss Promising Concussion Treatment in Upcoming Webinar
Biotechnology company Oragenics will host a management webinar to highlight its lead intranasal therapy ONP-002, currently in Phase IIa trials for mild traumatic brain injury, potentially addressing an unmet medical need in concussion treatment.
Quantum BioPharma Advances Multiple Sclerosis Drug Candidate Through Critical Toxicity Studies
Quantum BioPharma has completed key 90-day toxicity studies for its multiple sclerosis drug candidate Lucid-21-302, positioning the company to file an Investigational New Drug application with the FDA and potentially develop a first-in-class MS therapy.
American Heart Association Highlights Critical Health Risks for Women
The American Heart Association reveals key insights into cardiovascular-kidney-metabolic (CKM) health for women, emphasizing the interconnected nature of heart, kidney, and metabolic conditions and their potential long-term health implications.
Highland Park Dentist Offers Revolutionary Self-Administered Pain Relief Technique for Migraines and Headaches
Dr. Ira Shapira teaches patients and medical professionals a self-administered technique for Sphenopalatine Ganglion (SPG) Blocks, offering rapid pain relief for migraines, cluster headaches, and other autonomic cephalgias using a minimally invasive method.
UN Study Reveals Potential of AI to Reverse Global Development Setbacks
A recent UN study suggests artificial intelligence could play a critical role in addressing global human development challenges following significant disruptions like the COVID-19 pandemic. The research highlights AI's potential to restore and potentially accelerate progress in improving quality of life worldwide.
Research Uncovers Early Development Patterns of Pediatric Brain Tumors
A new study explores the complex origins of medulloblastoma in specialized nerve cells, potentially offering insights for future treatment strategies in pediatric brain cancer.
ABVC BioPharma Secures Japanese Patent for Innovative Depression Treatment
ABVC BioPharma has obtained a Japanese patent for its botanical-based Major Depressive Disorder treatment ABV-1504, expanding its global intellectual property portfolio and positioning the company for potential market entry in Japan's robust pharmaceutical landscape.
Simple Eye Exam Could Enable Early Parkinson's Detection, Researchers Find
A new study from Universite Laval suggests that a straightforward retinal examination might provide an early diagnostic method for Parkinson's disease, potentially transforming how medical professionals identify and track the neurological condition.
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
Clene Inc. reports promising progress on its CNM-Au8 therapy for ALS, with plans to submit a New Drug Application under the FDA's Accelerated Approval pathway, supported by significant survival data and reduced expenses.
Clene Inc. Advances Promising Therapy for ALS, Targets Accelerated FDA Approval
Clene Inc. reports significant progress on CNM-Au8, a potential breakthrough therapy for amyotrophic lateral sclerosis (ALS), with plans to submit a New Drug Application under the FDA's Accelerated Approval pathway in Q4 2025. New data demonstrates improved patient survival and neurological repair.
TransCode Therapeutics Advances RNA Cancer Therapy, Reaches Milestone in Phase 1a Trial
TransCode Therapeutics has successfully dosed 15 patients in its Phase 1a trial for RNA-based cancer therapeutic TTX-MC138, with early data showing promising target engagement and no significant toxicities.
NanoViricides Secures Ethics Approval for Mpox Phase II Trial in Democratic Republic of Congo
NanoViricides has received ethical clearance to conduct a Phase II clinical trial for NV-387, a broad-spectrum antiviral drug targeting Mpox, signaling potential progress in viral disease treatment strategies.
ESGold Discovers Promising Exploration Zone at Montauban Project in Quebec
ESGold Corp. has identified a significant geophysical anomaly in its Montauban Project, suggesting potential for volcanogenic massive sulfide deposits. The discovery could represent a strategic expansion of the company's mineral exploration efforts in Quebec.
Nancy Brown Named to TIME's 2025 List of Most Influential Health Leaders
Nancy Brown, CEO of the American Heart Association, has been recognized by TIME magazine as one of the 100 most influential individuals in global health, highlighting her transformative leadership in cardiovascular research and health innovation.
GeoVax Reveals Promising Dual-Action Vaccine with Potential COVID-19 and Mpox Protection
A novel vaccine candidate, GEO-CM04S1, demonstrates robust immunogenicity against both COVID-19 and Mpox in immunocompromised and healthy populations, offering potential breakthrough in infectious disease prevention.
Holistic Healing Practitioner Expands Expertise with Advanced Brain and Lymphatic Therapy Training
Carol McCoon, a holistic healing practitioner, is advancing her professional skills through specialized training in Brain Therapy and Lymph Drainage Therapy, offering personalized healing techniques that address neurological and lymphatic dysfunctions.
Newton Golf Company Revolutionizes Golf Equipment Through Physics-Driven Design
Newton Golf Company is transforming golf technology by applying scientific principles to shaft design, with innovative technology already gaining traction among professional golfers across multiple tours.
Foremost Clean Energy Completes Geophysical Survey at CLK Uranium Property
Foremost Clean Energy has conducted a high-resolution electromagnetic survey of its CLK Uranium Property in Saskatchewan's Athabasca Basin, with results expected to guide future exploration and drill targeting for potential uranium discovery.
Telomir Pharmaceuticals Advances Neurological Research with Novel Cellular Restoration Candidate
Telomir Pharmaceuticals reveals promising preclinical data for Telomir-1, a small molecule targeting cellular decline, with potential applications in autism spectrum disorder and rare neurological conditions. The research demonstrates potential breakthrough in understanding age-related cellular deterioration.
Clene Inc. to Present at D. Boral Capital Global Conference in New York
Clene Inc., a late clinical-stage biopharmaceutical company developing neurological disease treatments, will participate in the D. Boral Capital Inaugural Global Conference, offering investors an opportunity to learn about its innovative research and potential therapeutics.
Dynamic Global Events to Host Life Science Meeting Planners Summit in Philadelphia
Dynamic Global Events will convene top life science industry professionals for a networking and information-sharing summit in Philadelphia, addressing critical collaboration needs in the sector.
Spain Launches First Quantum Computer in Barcelona, Marking Technological Milestone
Spain has introduced its inaugural quantum computer at the Barcelona Supercomputing Center, positioning the country as a potential key player in emerging quantum technology. This development signals a significant leap forward in Spain's technological capabilities and potential scientific innovation.
Soligenix CEO Highlights Rare Disease Therapeutics and Public Health Solutions Strategy
Soligenix's CEO discusses the company's two-pronged business model focused on rare disease treatments and public health solutions, emphasizing significant government funding and promising clinical trial developments.
GeoVax Secures New Patent for Innovative Cancer Treatment Approach
GeoVax Labs has received a Notice of Allowance for a patent describing a novel triple-combination cancer therapy strategy targeting solid tumors with potential to minimize systemic toxicity and enhance treatment effectiveness.
Kairos Pharma to Showcase Oncology Research at D. Boral Capital Global Conference
Kairos Pharma will participate in the D. Boral Capital Inaugural Global Conference, offering investors insights into its innovative cancer therapeutic research, focusing on overcoming drug resistance with its lead candidate ENV105.
University of Utah Researchers Develop AI Tool to Predict Disease Onset Years in Advance
Researchers have created RiskPath, an open-source AI platform capable of forecasting long-term health conditions before symptoms emerge, potentially revolutionizing preventive healthcare approaches.